VC
Vaccinex, Inc.
VCNX · OTC
$1.06 +0.95% (+$0.01)
1M +36.62%
Market Cap $2.84M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
38 /100
Fair P/S 4.72x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 12.59%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 3,100.50%
Op. margin 3,117.30%
FCF margin 2,696.84%
Quality
61 /100
Average ROA 717.80%
Asset turnover 0.23x
ROIC 760.66%
Debt
3 /100
High Int. coverage -620.13x
Current ratio 0.50x
Net debt/EBITDA N/A
Stability
52 /100
Moderate Rev. volatility 299.19%
EPS volatility 19.97%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VCNX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Maurice Zauderer
Employees
25
Headquarters
Rochester
Prihajajoči dogodki
16 NOV.
Earnings
Upcoming earnings report